Iwanaga Naoki | Department of Second Internal Medicine, Nagasaki University School of Medicine

スポンサーリンク

概要

• Iwanaga Naokiの詳細を見る
• 同名の論文著者
• Department of Second Internal Medicine, Nagasaki University School of Medicineの論文著者

関連著者

• KOHNO Shigeru

  Department of Internal Medicine, Nagasaki University School of Medicine

• Soda Hiroshi

  Division of Clinical Infectious Diseases, Department of Internal Medicine, School of Medicine, Showa University

• Fukuda Yuichi

  Division of Respiratory Medicine, Sasebo City General Hospital

• Iwanaga Naoki

  Department of Second Internal Medicine, Nagasaki University School of Medicine

• Kitazaki Takeshi

  Division of Respiratory Medicine, Sasebo City General Hospital

• Adachi Misato

  Division of Respiratory Medicine, Senju Hospital

• Iwasaki Keisuke

  Division of Pathology, Sasebo City General Hospital

• Takazono Takahiro

  Department of Internal Medicine, Emergency and Critical Care Medical Center, Kitakyushu Municipal Ya

• Nakamura Shigeki

  Department Of General Medicine Nagasaki University School Of Medicine

• Iwasaki Keisuke

  Division Of Surgical Oncology Department Of Surgery Nagasaki University Graduate School Of Biomedica

• Yanagihara Katsunori

  Department Of Clinical Laboratory Nagasaki University Hospital

• Soda Hiroshi

  Division of Respiratory Medicine, Sasebo City General Hospital

• Kohno Shigeru

  Department of Second Internal Medicine, Nagasaki University School of Medicine

• Tashiro Takayoshi

  Department of Health Sciences, Nagasaki University Graduate School of Biomedical Sciences

• Soda Hiroshi

  Division of Respiratory Medicine, Sasebo City General Hospital, Japan

• Imamura Yoshifumi

  Department of Chemistry, Faculty of Science, Nagoya University

• Izumikawa Koichi

  Department of Hospital Epidemiology and Infection Control, Nagasaki University Infection Control and Education Center (NICE), Nagasaki University Hospital, Japan

もっと見る 閉じる

著作論文

• Gefitinib Improves Bronchorrhea from Mucinous Bronchioloalveolar Carcinoma and Serum Surfactant Protein-D Levels is a Novel Surrogate Predictor of Treatment Benefit
• A Fatal Case of Acute Myocardial Infarction following the Improvement of Influenza A(H1N1)pdm2009-related Acute Myocarditis
• Gefitinib Improves Bronchorrhea from Mucinous Bronchioloalveolar Carcinoma and Serum Surfactant Protein-D Levels is a Novel Surrogate Predictor of Treatment Benefit

スポンサーリンク